Literature DB >> 10630777

Effect of three loading doses of warfarin on the international normalized ratio for dogs.

E Monnet1, M R Morgan.   

Abstract

OBJECTIVE: To evaluate effect of 3 loading doses of warfarin sodium on the international normalized ratio (INR) for dogs. ANIMALS: 18 dogs weighing between 25 and 30 kg. PROCEDURE: Dogs were randomly allocated into 3 groups and received 2, 4, or 6 mg of warfarin administered orally once a day for 2 days after surgery for bilateral iliac artery grafting. Activated partial thromboplastin (APTT) and prothrombin times (PT) were measured before and after treatment. Prothrombin time also was reported as an international normalized ratio.
RESULTS: The APTT were not significantly different among groups before or after treatment. The INR and PT were significantly increased in all groups after treatment. The INR and PT of the 6-mg group were significantly greater than those of the 2-mg and 4-mg groups. None of the dogs had clinical evidence of bleeding. CONCLUSIONS AND CLINICAL RELEVANCE: A warfarin loading dose of 6 mg/d can be safely administered for 2 days to dogs weighing between 25 and 30 kg. Anticoagulation can be achieved safely in dogs in 2 days by use of warfarin. The effects of warfarin can be monitored with the INR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10630777     DOI: 10.2460/ajvr.2000.61.48

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Warfarin therapy in a dog with acute arterial thrombosis and pyometra.

Authors:  Shiori Arai; Mary Beth Callan
Journal:  Can Vet J       Date:  2014-11       Impact factor: 1.008

2.  Prostate histotripsy in an anticoagulated model.

Authors:  Jeffery C Wheat; Timothy L Hall; Christopher R Hempel; Charles A Cain; Zhen Xu; William W Roberts
Journal:  Urology       Date:  2009-11-22       Impact factor: 2.649

3.  Effect of tecarfarin, a novel vitamin K epoxide reductase inhibitor, on coagulation in beagle dogs.

Authors:  A Choppin; I Irwin; L Lach; M G McDonald; A E Rettie; L Shao; C Becker; M P Palme; X Paliard; S Bowersox; D M Dennis; P Druzgala
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.